S100A4 hypomethylation affects epithelial–mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma

Molecular Carcinogenesis

Volumn 55, Issue 10, 2016, Pages 1467-1476

  Lin, Zhe ^a   Deng, Lei ^b   Ji, Jie ^b   Cheng, Ci ^a   Wan, Xin ^a   Jiang, Runqiu ^b   Tang, Junwei ^b   Zhuo, Han ^b   Sun, Beicheng ^b   Chen, Yun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

EMT; hypomethylation; LMP2A; NPC; S100A4

Indexed keywords

CALVASCULIN; DECITABINE; DNA METHYLTRANSFERASE; LATENT MEMBRANE PROTEIN 2; MESSENGER RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ECTOPIC EXPRESSION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR INVASION;

EID: 84986913574     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22389     Document Type: Article

References (38)

1. Wei WI, Sham JST. Nasopharyngeal carcinoma. Lancet 2005; 365:2041–2054
2. Ong YK, Heng DM, Chung B, Leong SS, Wee J, Fong KW, et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer 2003; 39:1535–1541.
3. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010; 6:e1000940.
4. Brooks L, Yao Q, Rickinson A, Young L. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992; 66:2689–2697.
5. Hitt M, Allday M, Hara T, Karran L, Jones M, Busson P, et al. EBV gene expression in an NPC-related tumour. EMBO J 1989; 8:2639.
6. Young L, Dawson C, Clark D, Rupani H, Busson P, Tursz T, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988; 69:1051–1065.
7. Heussinger N, Buttner M, Ott G, Brachtel E, Pilch BZ, Kremmer E, et al. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol 2004; 203:696–699.
8. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein S100A4: Role in tumour progression and metastasis. Br J Cancer 2005; 92:1955–1958.
9. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem 2006; 281:677–680.
10. Schneider M, Hansen JL, Sheikh SP. S100A4: A common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?. J Mol Med (Berl) 2008; 86:507–522.
11. Ismail TM, Zhang S, Fernig DG, Gross S, Martin-Fernandez ML, See V, et al. Self-association of calcium-binding protein S100A4 and metastasis. J Biol Chem 2010; 285:914–922.
12. Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: Preclinical and clinical evidence. Cancer Metastasis Rev 2012; 31:163–172.
13. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 2006; 103:14825–14830.
14. Miranda KJ, Loeser RF, Yammani RR. Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13. J Biol Chem 2010; 285:31517–31524.
15. Xie R, Schlumbrecht MP, Shipley GL, Xie S, Bassett RL, Jr., Broaddus RR. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. Lab Invest 2009; 89:937–947.
16. Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI, Lin SC, et al. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res 2011; 71:1912–1923.
17. Chen M, Bresnick AR, O'Connor KL. Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells. Oncogene 2013; 32:3754–3764.
18. Orre LM, Panizza E, Kaminskyy VO, Vernet E, Graslund T, Zhivotovsky B, et al. S100A4 interacts with p53 in the nucleus and promotes p53 degradation. Oncogene 2013; 32:5531–5540.
19. Hansen MT, Forst B, Cremers N, Quagliata L, Ambartsumian N, Grum-Schwensen B, et al. A link between inflammation and metastasis: Serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4. Oncogene 2015; 34:424–435.
20. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 2010; 6:e1000917.
21. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 2008; 68:8954–8967.
22. Nakamura N, Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 1998; 16:471–479.
23. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with Poor differentiation and DNA hypomethylation. Am J Pathol 2002; 160:45–50.
24. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003; 63:4158–4166.
25. Rehman I, Goodarzi A, Cross SS, Leiblich A, Catto JW, Phillips JT, et al. DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer. Prostate 2007; 67:341–347.
26. Xie R, Loose DS, Shipley GL, Xie S, Bassett RL, Jr, Broaddus RR. Hypomethylation-induced expression of S100A4 in endometrial carcinoma. Mod Pathol 2007; 20:1045–1054.
27. Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, et al. Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res 2014; 20:187–198.
28. Lin Z, Wan X, Jiang R, Deng L, Gao Y, Tang J, et al. EBV-encoded LMP2A Promotes EMT in Nasopharyngeal Carcinoma via MTA1 and mTOR Signaling Induction. J Virol 2014; 88:11872–11885.
29. Sack U, Walther W, Scudiero D, Selby M, Aumann J, Lemos C, et al. S100A4-induced cell motility and metastasis is restricted by the Wnt/beta-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell 2011; 22:3344–3354.
30. Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, et al. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 2006; 131:1486–1500.
31. Wade PA. Methyl CpG binding proteins: Coupling chromatin architecture to gene regulation. Oncogene 2001; 20:3166–3173.
32. Boye K, Maelandsmo GM. S100A4 and metastasis: A small actor playing many roles. Am J Pathol 2010; 176:528–535.
33. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 2002; 8:131–137.
34. Sakuma K, Chong JM, Sudo M, Ushiku T, Inoue Y, Shibahara J, et al. High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2004; 112:273–278.
35. Saito M, Nishikawa J, Okada T, Morishige A, Sakai K, Nakamura M, et al. Role of DNA methylation in the development of Epstein-Barr virus-associated gastric carcinoma. J Med Virol 2013; 85:121–127.
36. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009; 69:2766–2774.
37. Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem 2009; 284:1484–1494.
38. Poplineau M, Schnekenburger M, Dufer J, Kosciarz A, Brassart-Pasco S, Antonicelli F, et al. The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells. Mol Carcinog 2015; 54:24–34.